Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. It is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. It makes products for use across many industries, including healthcare, industrial chemicals, agriculture and academic research.
높은 성장
회사의 매출은 지난 3년간 꾸준히 성장해왔으며, 연평균 53.75%의 증가율을 기록했습니다.
과소 평가된
회사의 최신 PE은 -18.80로, 최근 3년 기준 낮은 백분위 범위에 속합니다.
기관 매도
최신 기관 보유 주식 수는 70.44M주이며, 전 분기 대비 0.43% 감소했습니다.
캐서린 우드가 보유
스타 투자자 캐서린 우드이(가) 이 주식 6.40M주를 보유하고 있습니다.
시장 활동 증가
회사는 투자자들의 관심이 높아져, 최근 20일간 회전율이 0.78입니다.